Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies
Hui Yi Chew, Priscila Oliveira de Lima, Jazmina L. G. Cruz, et al.
Cell (2020) Vol. 180, Iss. 5, pp. 895-914.e27
Open Access | Times Cited: 152

Showing 26-50 of 152 citing articles:

Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma
Jinfang Cui, Yuchao He, Fuyi Zhu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 13, pp. 4061-4081
Open Access | Times Cited: 15
Repurposing phenothiazines for cancer therapy: compromising membrane integrity in cancer cells
Syrina Mehrabi, S.Abdullahi Elmi, Jesper Nylandsted
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 14
Targeting autophagy by antipsychotic phenothiazines: potential drug repurposing for cancer therapy
Rayssa de Mello Lopes, Ana Carolina Santos de Souza, Michał Otręba, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116075-116075
Closed Access | Times Cited: 5
Synergically enhanced anti-tumor immunity of in vivo CAR by circRNA vaccine boosting
Yanyan Wang, Liangru Lin, Xinyue Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 5
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib
Arturo Simoni‐Nieves, Moshit Lindzen, Suvendu Giri, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 9, pp. 101703-101703
Open Access | Times Cited: 5
Inhibition of PAI-1 Blocks PD-L1 Endocytosis and Improves the Response of Melanoma Cells to Immune Checkpoint Blockade
Yu‐Ju Tseng, Chih‐Hung Lee, Wei‐Yu Chen, et al.
Journal of Investigative Dermatology (2021) Vol. 141, Iss. 11, pp. 2690-2698.e6
Open Access | Times Cited: 29
Weaponizing natural killer cells for solid cancer immunotherapy
Joshua K.M. Wong, Riccardo Dolcetti, Handoo Rhee, et al.
Trends in cancer (2022) Vol. 9, Iss. 2, pp. 111-121
Open Access | Times Cited: 22
Regulation of PD-L1 Trafficking from Synthesis to Degradation
Eyoel Yemanaberhan Lemma, Anudari Letian, Nasser K. Altorki, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 7, pp. 866-874
Open Access | Times Cited: 13
Insights into the role of derailed endocytic trafficking pathway in cancer: From the perspective of cancer hallmarks
Hongjie Guo, Chen Zhou, Mingming Zheng, et al.
Pharmacological Research (2024) Vol. 201, pp. 107084-107084
Open Access | Times Cited: 4
Clicking of organelle-enriched probes for fluorogenic imaging of autophagic and endocytic fluxes
Xianjun Liu, Mei‐Hao Xiang, Wenjing Zhou, et al.
Chemical Science (2021) Vol. 12, Iss. 16, pp. 5834-5842
Open Access | Times Cited: 24
Epidermal growth factor potentiates EGFR(Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium
Peiyu Wang, Renwu Zhou, Rusen Zhou, et al.
Redox Biology (2023) Vol. 69, pp. 102976-102976
Open Access | Times Cited: 11
Glypicans, 35 years later
Jorge Filmus
Proteoglycan Research (2023) Vol. 1, Iss. 2
Open Access | Times Cited: 10
Immuno-PET and Targeted α-Therapy Using Anti–Glypican-1 Antibody Labeled with89Zr or211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma
Tadashi Watabe, Kazuya Kabayama, Sadahiro Naka, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 12, pp. 1949-1955
Open Access | Times Cited: 10
Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma.
Katarzyna Radke, Kristina Aaltonen, Erick Andrés Muciño-Olmos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Dynole‐Based Dynamin Inhibitors as Novel Cytotoxic Agents
Jennette A. Sakoff, Mohammed K. Abdel‐Hamid Amin, Mark J. Robertson, et al.
ChemistrySelect (2025) Vol. 10, Iss. 5
Open Access
Therapeutic Mechanisms of Phenothiazine Drugs: A Mini-Review of Advances in Cancer Treatment and Antibiotic Resistance
Xiangyu Zou, Bai Xie
Deleted Journal (2025) Vol. 24, Iss. 1
Open Access
Novel antibody cocktail therapy targeting extracellular tumor-specific mutations to treat triple-negative breast cancer
Stephanie C. Pero, Girja S. Shukla, Yujing Sun, et al.
Research Square (Research Square) (2025)
Closed Access
TLR4 endocytosis and endosomal TLR4 signaling are distinct and independent outcomes of TLR4 activation
Thomas E Schultz, Carmen D Mathmann, Leslie C Domínguez Cadena, et al.
EMBO Reports (2025)
Open Access
Identification and characterization of Bufalin as a novel EGFR degrader
Yidi Tai, Lulu Kong, Yan Wang, et al.
Cancer Letters (2025), pp. 217715-217715
Closed Access
ADCC: the rock band led by therapeutic antibodies, tumor and immune cells
Roos Vincken, Uxue Armendáriz-Martínez, Ana Ruiz-Sáenz
Frontiers in Immunology (2025) Vol. 16
Open Access
Recycling of Trans‐Golgi SNAREs Promotes Apoplastic Effector Secretion for Effective Host Invasion in Magnaporthe oryzae
Lili Lin, Qiuqiu Wu, Shuang Wang, et al.
Plant Cell & Environment (2025)
Closed Access
Acute Statin Treatment Improves Antibody Accumulation in EGFR- and PSMA-Expressing Tumors
Patrícia M. R. Pereira, Komal Mandleywala, Ashwin Ragupathi, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 23, pp. 6215-6229
Open Access | Times Cited: 27
Lymph-directed immunotherapy – Harnessing endogenous lymphatic distribution pathways for enhanced therapeutic outcomes in cancer
Orlagh M. Feeney, Gracia Gracia, Daniel H.S. Brundel, et al.
Advanced Drug Delivery Reviews (2020) Vol. 160, pp. 115-135
Open Access | Times Cited: 25
Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells
Cédric S. Tremblay, Sung Kai Chiu, Jesslyn Saw, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Forcing a growth factor response – tissue-stiffness modulation of integrin signaling and crosstalk with growth factor receptors
Farhana A. Sarker, Victoria Prior, Samuel Bax, et al.
Journal of Cell Science (2020) Vol. 133, Iss. 23
Open Access | Times Cited: 24

Scroll to top